WWM
ABBV icon

Wolff Wiese Magana’s AbbVie ABBV Stock Holding History

Wolff Wiese Magana’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6M Sell
18,267
-725
-4% -$156K 2.11% 7
2026
Q1 		$4.13M Buy
18,992
+1,007
+6% +$223K 2.28% 6
2025
Q4 		$4.11M Buy
17,985
+227
+1% +$51.7K 2.25% 6
2025
Q3 		$4.11M Sell
17,758
-135
-0.8% -$27.5K 2.33% 6
2025
Q2 		$3.32M Sell
17,893
-111
-0.6% -$20.6K 2.06% 7
2025
Q1 		$3.77M Sell
18,004
-93
-0.5% -$18.1K 2.57% 5
2024
Q4 		$3.22M Buy
18,097
+1,750
+11% +$322K 2.13% 8
2024
Q3 		$3.23M Buy
16,347
+646
+4% +$121K 2.21% 8
2024
Q2 		$2.69M Sell
15,701
-60
-0.4% -$9.94K 2.14% 9
2024
Q1 		$2.87M Sell
15,761
-422
-3% -$72.7K 2.47% 6
2023
Q4 		$2.51M Sell
16,183
-1,212
-7% -$177K 2.38% 7
2023
Q3 		$2.59M Buy
17,395
+45
+0.3% +$6.61K 2.11% 8
2023
Q2 		$2.34M Sell
17,350
-9,455
-35% -$1.39M 1.8% 11
2023
Q1 		$4.27M Sell
26,805
-48
-0.2% -$7.34K 3.47% 3
2022
Q4 		$4.34M Sell
26,853
-571
-2% -$87.6K 3.72% 1
2022
Q3 		$3.68M Buy
27,424
+55
+0.2% +$7.89K 2.96% 3
2022
Q2 		$4.19M Sell
27,369
-3,084
-10% -$471K 3.06% 3
2022
Q1 		$4.94M Buy
30,453
+83
+0.3% +$12.1K 3.31% 3
2021
Q4 		$4.11M Sell
30,370
-411
-1% -$48.5K 2.66% 3
2021
Q3 		$3.32M Buy
30,781
+541
+2% +$61.8K 2.34% 3
2021
Q2 		$3.41M Sell
30,240
-443
-1% -$49.9K 2.43% 4
2021
Q1 		$3.32M Buy
30,683
+746
+2% +$79.8K 2.59% 3
2020
Q4 		$3.21M Buy
+29,937
New +$2.88M 2.71% 3

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wolff Wiese Magana's ABBV Position: Q2 2026 in Review

Wolff Wiese Magana reduced its AbbVie (ABBV) stake by 3.8% in Q2 2026, selling an estimated $156K and leaving 18,267 shares worth $4.6M. The position accounts for 2.11% of the portfolio, ranked #7.

Wolff Wiese Magana first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.94M in Q1 2022. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wolff Wiese Magana held 18,267 shares of AbbVie worth $4.6M as of Q2 2026.
  • Wolff Wiese Magana sold 725 AbbVie shares in Q2 2026, an estimated $156K.
  • AbbVie made up 2.11% of Wolff Wiese Magana's portfolio in Q2 2026, its #7 holding.
  • Wolff Wiese Magana first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's AbbVie position peaked at $4.94M in Q1 2022.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.